Monthly information on share capital and company voting rights
Cellectis has reported its monthly share capital and voting rights information as of October 31, 2024. The company disclosed a total of 100,093,873 shares in the capital and 88,569,210 voting rights. This disclosure is made in compliance with Article 223-16 of the General Regulation of the French financial markets authority for its listing on Euronext Growth under ISIN code FR0010425595.
Cellectis ha riportato le informazioni relative al capitale sociale e ai diritti di voto aggiornate al 31 ottobre 2024. L'azienda ha comunicato un totale di 100.093.873 azioni nel capitale e 88.569.210 diritti di voto. Questa comunicazione è effettuata in conformità con l'Articolo 223-16 del Regolamento Generale dell'autorità dei mercati finanziari francesi per la sua quotazione su Euronext Growth con codice ISIN FR0010425595.
Cellectis ha informado sobre su capital social mensual y los derechos de voto al 31 de octubre de 2024. La empresa reveló un total de 100.093.873 acciones en el capital y 88.569.210 derechos de voto. Esta divulgación se realiza de acuerdo con el Artículo 223-16 del Reglamento General de la autoridad de los mercados financieros franceses para su cotización en Euronext Growth bajo el código ISIN FR0010425595.
Cellectis는 2024년 10월 31일 기준으로 월간 자본금 및 의결권 정보를 보고했습니다. 회사는 총 100,093,873주의 자본과 88,569,210개의 의결권을 공시했습니다. 이 공시는 Euronext Growth에 상장하기 위해 프랑스 금융 시장 당국의 일반 규정 제223-16조에 따른 것입니다. ISIN 코드 FR0010425595로 listed 되어 있습니다.
Cellectis a rapporté ses informations mensuelles sur le capital social et les droits de vote au 31 octobre 2024. La société a divulgué un total de 100.093.873 actions dans le capital et 88.569.210 droits de vote. Cette divulgation est faite conformément à l'article 223-16 du Règlement Général de l'autorité des marchés financiers français pour son inscription sur Euronext Growth sous le code ISIN FR0010425595.
Cellectis hat am 31. Oktober 2024 Informationen über sein monatliches Grundkapital und die Stimmrechte veröffentlicht. Das Unternehmen gab insgesamt 100.093.873 Aktien im Kapital und 88.569.210 Stimmrechte bekannt. Diese Bekanntgabe erfolgt gemäß Artikel 223-16 der Allgemeinen Vorschriften der französischen Finanzmarktaufsichtsbehörde für die Notierung an Euronext Growth unter der ISIN FR0010425595.
- None.
- None.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, Nov. 06, 2024 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 10/31/2024 | 100,093,873 | 88,569,210 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Attachment
FAQ
How many shares does Cellectis (CLLS) have as of October 31, 2024?
What is the total number of voting rights for Cellectis (CLLS) in October 2024?
On which exchange is Cellectis (CLLS) listed according to the October 2024 report?
